Analysen von Terence Flynn
| 10.05.23 | BioNTech (ADRs) Equal-weight | Morgan Stanley | |
| 29.07.21 | Pfizer Neutral | Goldman Sachs Group Inc. | |
| 24.05.21 | Pfizer Neutral | Goldman Sachs Group Inc. | |
| 13.05.21 | Pfizer Neutral | Goldman Sachs Group Inc. | |
| 31.03.21 | Pfizer Neutral | Goldman Sachs Group Inc. | |
| 12.03.21 | Pfizer Neutral | Goldman Sachs Group Inc. | |
| 10.03.21 | Pfizer Neutral | Goldman Sachs Group Inc. | |
| 09.03.21 | Pfizer Neutral | Goldman Sachs Group Inc. | |
|
Werbung
|
|||
| 21.01.21 | Pfizer Neutral | Goldman Sachs Group Inc. | |
| 08.01.21 | Pfizer Neutral | Goldman Sachs Group Inc. | |
| 14.12.20 | Pfizer Neutral | Goldman Sachs Group Inc. | |
| 11.12.20 | Pfizer Neutral | Goldman Sachs Group Inc. | |
| 02.12.20 | Pfizer Neutral | Goldman Sachs Group Inc. | |
| 29.10.19 | Merck Neutral | Goldman Sachs Group Inc. | |
| 14.12.12 | Amgen neutral | Goldman Sachs Group Inc. | |
| 14.12.12 | Celgene neutral | Goldman Sachs Group Inc. | |
| 14.12.12 | Gilead Sciences neutral | Goldman Sachs Group Inc. | |